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Abstract 
 
Objectives: Treatment guidelines for eating disorders (ED) are unclear about 
the optimal length of psychological care. We aimed to investigate 
associations between treatment duration and changes in ED pathology. 
Method: Data for 164 outpatients accessing psychological interventions for 
ED were analyzed using MANOVA. We tested associations between number 
of therapy sessions and pre-post treatment changes in clinical outcomes 
(EDE-Q global scores, binge eating, purging); adjusting for baseline 
measures, diagnoses and treatment type. Secondary analyses included rapid 
response variables in the above outcomes by treatment session eight. Partial 
correlations between treatment duration and BMI changes (adjusting for 
intake BMI) were examined for anorexia nervosa cases. 
Results: Treatment duration was not significantly associated with changes in 
ED outcomes after adjusting for rapid response. BMI change (weight regain) 
was not correlated with treatment duration in anorexia nervosa cases. Rapid 
response was associated with better EDE-Q outcomes, but not with changes 
in binge eating or purging behaviors. 
Discussion: ED outcomes are unrelated to treatment duration; rapid 
response is a useful prognostic indicator for treatment planning. 
 
Key words: eating disorders, anorexia nervosa, bulimia nervosa, 
psychological therapy 
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Clinical guidelines for the management of eating disorders 
recommend that up to 20 sessions of psychological care should be offered 
over the course of four to twelve months, though it is recognized that 
conditions such as anorexia nervosa may require longer treatments.1,2 These 
recommendations are informed by clinical experience and data from 
controlled trials of time-limited interventions.3 To date, there is little 
evidence on the relationship between treatment duration and changes in 
eating disorders pathology. However, it has been shown that symptomatic 
improvements during the earlier stages of therapy (i.e., rapid response by 
sessions 4 to 6) tend to be associated with better outcomes after treatment 
for a variety of eating disorders.4-9 
 Outside of the eating disorders field, there is a growing body of 
research on treatment duration and clinical improvement. In a citation 
classic, Howard et al.10 introduced the notion of dose-response in 
psychotherapy, showing a curvilinear relationship between the number of 
therapy sessions and the percentage of improving patients. According to 
their analysis of 2431 cases with heterogeneous diagnoses accessing various 
psychological treatment models, they concluded that 26 sessions marks the 
point at which 75% of patients improve, after which further gains are rare. 
They also argued that the dose at which 50% of patients improve (6 to 8 
sessions) can be used as a criterion for a fair trial of treatment, at which 
point individual cases should be assessed to determine if further sessions 
are likely to be beneficial. This dose-response effect has been replicated in 
several studies and clinical populations.11-17 
A consistent observation across these studies is that of diminishing 
gains after a specific number of sessions, however the ‘optimal dose’ varies 
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across samples. For instance, the optimal dose in guided self-help for mild-
to-moderate depression and anxiety problems appears to be between 4 to 6 
sessions,13 whereas Hansen and Lambert14 estimated an optimal dose of 16 
sessions of intensive psychotherapy in a heterogeneous sample of patients in 
community mental health centers. It is also evident that different problem 
domains change at different stages of therapy. For example, acute 
psychiatric symptoms appear to remit earlier compared to social and 
interpersonal problems.12,16,17 
In summary, the dose-response effect has been documented in several 
psychological therapy studies and clinical populations. However, the 
association between treatment duration and therapeutic change varies 
according to specific outcome domains. In particular, it is unclear if and how 
eating disorder pathology may be associated with treatment duration after 
adjusting for the influence of rapid response. Therefore, the primary aim of 
this study was to examine associations between the number of treatment 
sessions and changes in eating disorder pathology in a clinical sample of 
outpatients accessing psychological interventions. 
 
METHODS 
 
Setting and interventions 
Data for this study were collected as part of outpatient psychological 
care offered in a specialist eating disorders service in Nottinghamshire, 
England. The service offered psychological interventions delivered by post-
graduate level psychotherapists, counsellors and clinical psychologists. 
Interventions included cognitive behavioral therapy, cognitive analytic 
therapy, person centered counselling, gestalt therapy, integrative 
LENGTH OF THERAPY FOR E.D. 
 5 
psychotherapy, and eye-movement desensitization and reprocessing (EMDR) 
for trauma related conditions. Treatment duration was decided on an 
individual case basis and could have been up to 18 months. 
 
Measures and data sources 
All patients above the age of 18 treated between September 2012 and 
October 2015 provided consent for the use of their anonymous clinical 
information for service evaluation and research. Patients attended an initial 
assessment meeting with the clinical lead or a senior psychotherapist prior 
to starting therapy. Baseline assessments included a semi-structured 
interview guided by standard diagnostic criteria,18 supplemented by self-
reported measures of eating disorder pathology (EDE-Q)19 and functional 
impairment (CIA).20 The body mass index (BMI) was calculated at baseline 
and final assessments, based on height / weight measurements taken at the 
clinic. BMI was only assessed in cases of anorexia nervosa or cases of 
atypical anorexia nervosa that had rapid weight loss at referral but were still 
in the healthy BMI range at intake assessments (classified as EDNOS - 
eating disorder not otherwise specified). After starting therapy, patients were 
asked to self-complete the above measures at an eight week review session 
and at the final therapy session.  
The Eating Disorder Examination Questionnaire is a 36 item measure 
of ED psychopathology,19 with adequate internal consistency, test-retest 
reliability and criterion validity.21,22 The EDE-Q has four subscales: restraint, 
eating concern, shape concern, and weight concern. An EDE-Q global score 
can be derived for outcome measurement by estimating the mean of the 22 
Likert scale items assessing the core attitudinal features of ED 
psychopathology. Cronbach’s alpha in this study sample for the EDE-Q 
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global score items was α = .92. EDE-Q also captures behavioral aspects of 
ED pathology, including single items quantifying the frequency of binge 
eating and purging episodes in the last month. 
The Clinical Impairment Assessment (CIA) is a 16 item measure of 
psychosocial impairment related to eating disorder pathology; with adequate 
internal consistency, construct and discriminant validity.20 The items can be 
self-rated using 4-point Likert scales, which are summed to derive a global 
impairment rating. Cronbach’s alpha for the CIA items in this sample was α 
= .90. 
Additional data sources included demographics (age, gender, 
ethnicity), the type of psychological therapy received (coded according to the 
therapist’s theoretical orientation), and the total number of sessions 
attended. 
 
Sample characteristics 
The analysis included 164 cases with available baseline EDE-Q data 
and who attended at least 1 therapy session. Most patients were females 
(95.1%), with a mean age of 30.13 years (SD = 9.64; range: 18 to 60) and of a 
White British background (97.6%). Initial assessments (guided by DSM-IV 
criteria)23 indicated that 26.8% presented with bulimia nervosa, 14.0% with 
anorexia nervosa, 13.4% with binge eating disorder, and 45.7% with 
EDNOS. Mean baseline EDE-Q global scores, behavioral measures and BMI 
estimates are described in Table 1. Clinical records indicated that 59.8% 
completed treatment, 20.1% dropped out (unilateral discontinuation of 
treatment), and the remaining cases were referred on to other services by 
mutual agreement. 
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Clinical interventions recorded in case records were integrative 
psychotherapy (41.5% of cases), cognitive behavioral therapy (18.3%), person 
centered counselling (12.2%), cognitive analytic therapy (12.2%), gestalt 
therapy (11.6%) and EMDR (4.3%). The mean number of attended therapy 
sessions was 16.23 (SD = 12.97; range = 1 to 76). 
 
Statistical analyses 
We formulated an analysis plan in 3 steps aiming to: (1) deal with 
missing data; (2) to summarize clinical outcomes; and (3) to investigate 
associations between treatment duration, rapid response and pre-post 
treatment outcomes. 
In the first step we expected that some data were missing 
systematically since some patients dropped out or were referred to other 
services prior to completing the final outcome measures. To deal with this, 
we applied multiple imputation using an expectation maximization 
method.24 In addition, we applied logistic regression, where all baseline 
demographic and clinical variables were used to predict cases with missing 
(vs. complete) outcomes data at the end of treatment. The predicted 
probabilities from this model were transformed to inverse probability weights 
(IPW) which enabled us to appropriately weight cases with missing/imputed 
data.25 
In the second step we calculated pre-post treatment effect sizes 
(Cohen’s d) weighted by sample size for EDE-Q global scores, EDE-Q 
behavioral measures (binge eating, purging frequencies) and BMI. The total 
percentage of cases meeting criteria for reliable and clinically significant 
improvement (RCSI) in EDE-Q global scores was calculated based on 
Jacobson and Truax criteria,26 applying a diagnostic cut-off of 2.77 and a 
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reliable change index of 1.13 which were derived from norms reported by 
Fairburn and Beglin.19 We also compared the post-treatment EDE-Q global 
score for the study sample to published normative data,27 following the 
methodological recommendations by Bardone-Cone et al.28 
In the third step, we undertook a series of tests to examine if length of 
treatment is associated with attitudinal (EDE-Q global score), behavioral 
(EDE-Q binge eating and purging measures) and physical (BMI) outcome 
indicators. We started by examining the distribution of target variables and 
checking model assumptions. Preliminary analyses were based on univariate 
regression models predicting change scores (baseline – final measure, where 
a positive score denotes improvement) for each of the three EDE-Q outcomes 
to assess if treatment sessions are better modelled as a continuous, 
polynomial (quadratic or cubic) or log-transformed variable. Goodness-of-fit 
was based on assessing the AIC, BIC statistics and -2 log likelihood tests. 
Preliminary tests confirmed that a log-transformed sessions variable offered 
the best fit to the data (i.e., statistically significant reduction in -2 log 
likelihood from linear model to log-transformed model), so all subsequent 
analyses included the transformed variable. We also found that change 
scores for the two EDE-Q behavioral variables were not normally distributed, 
so subsequent analyses would need to be robust to potential violations of 
regression model assumptions. 
The primary analysis applied MANOVA, which allows the values of 
multiple dependent scale variables to be modelled in a single analysis based 
on their relationships to predictors, reducing the chance for spurious 
findings that are possible when performing multiple tests of significance in 
the same data. Change scores in the three EDE-Q outcome measures (global 
score, binge eating, purging) were entered as dependent variables. Predictors 
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included diagnosis, type of therapy, baseline EDE-Q measures (described 
above), baseline CIA, and a log-transformed sessions variable. The model 
was run with inverse probability weights (explained above) and repeated 
1,000 times using bootstrap resampling to address the uncertainty around 
the sample distributions for EDE-Q behavioral measures. We performed two 
additional sensitivity analyses to check the robustness of findings. The 
MANOVA with bootstrap resampling was repeated using winsorized data for 
the EDE-Q behavioral measures to check if extreme outliers may have 
influenced results. The analysis was also repeated in a subsample (n = 142) 
that excluded anorexia nervosa cases to assess if this particular group may 
have biased the results in some way, since prior studies have suggested that 
EDE-Q may not be sensitive enough to detect meaningful changes in AN 
cases.29 
Next, we undertook an analysis of ‘rapid response’, using data from 
the subsample of cases (n = 111) that had an assessment at session eight 
and who attended at least nine therapy sessions (so that the final session 
measure was not confounded with the eight-week assessment). We repeated 
the above MANOVA strategy and sensitivity analyses entering a binary 
variable for ‘rapid response’ in each of the EDE-Q measures. To determine 
rapid response in global EDE-Q scores, cases coded ‘1’ had EDE-Q change 
scores ≥ 1.13 (reliable change index) by session eight, and cases coded ‘0’ did 
not show reliable improvement. Rapid responders in behavioral measures 
had reduced their monthly binge eating or purging episodes by at least 70% 
by session eight, based on definitions of rapid response applied in previous 
community sample studies.6 
Given the restricted number of cases with available BMI data, only 
partial correlations were applied to investigate relationships between length 
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of treatment (log-transformed sessions) and BMI change scores (adjusting for 
baseline BMI). The BMI change score (final – initial BMI) was coded such 
that a positive value indicated an increase and a negative value indicated a 
reduction in BMI after treatment. Partial correlations were carried out in the 
sample of cases with available BMI data (n = 32) and repeated in the 
subsample of AN cases (n = 22) excluding atypical cases that were classified 
under the EDNOS diagnosis. 
 
[Table 1] 
 
RESULTS 
Clinical outcomes 
Table 1 summarizes pre-post treatment clinical outcome measures. 
Effect sizes reflected small (d = 0.32 for changes in purging) to large (d = 
1.42 for changes in EDE-Q global scores) estimates of improvement across 
outcome domains. The large effect size for BMI gain in AN cases (d = 0.89) 
contrasts with the moderate effect (d = 0.49) observed in the sample 
including EDNOS cases, since the therapeutic goal for the latter cases was to 
maintain a healthy BMI. Between 21.7% and 34.8% of cases met criteria for 
rapid response by treatment session eight. Overall, 54.5% of all cases met 
RCSI criteria by the end of treatment. The mean post-treatment EDE-Q 
global score (2.54) was within 1 standard deviation of the mean score for an 
age-matched normative sample (EDE-Q global score = 1.58, SD = 1.23).28 
 
Treatment duration and treatment outcomes 
Bootstrap parameter estimates for the primary MANOVA analysis 
suggested that treatment duration was not significantly associated with 
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changes in EDE-Q global scores (B = -0.06, SE = 0.35, p = 0.88) or binge 
eating behaviors (B = 1.22, SE = 1.02, p = 0.23), but duration was positively 
associated with improvement in purging behaviors (B = 3.47, SE = 1.54, p = 
0.03). As expected, higher baseline measures were significantly associated 
with changes in the corresponding dependent variables (main effects for 
baseline measures had positive coefficients and p < 0.01). Higher baseline 
binge eating behaviors were negatively associated with changes in purging 
behaviors (B = -0.30, SE = 0.09, p < 0.01). The contrasts between treatment 
modalities suggested that CBT was positively associated with improved EDE-
Q global scores (B = 0.70, SE = 0.33, p = 0.03), but no differences were 
found between treatments in behavioral change measures (all p > 0.05). No 
other variables were significantly associated with treatment outcomes. 
Sensitivity analyses yielded the same results and association patterns, 
suggesting the results were not unduly influenced by extreme outliers or AN 
cases. 
 
Analysis of rapid response 
After adjusting for rapid response in secondary MANOVA analyses, 
the main effect for treatment duration was not significantly associated with 
changes in EDE-Q global scores (B = -0.15, SE = 0.73, p = 0.84), binge 
eating (B = -0.76, SE = 2.68, p = 0.79) or purging behaviors (B = 3.35, SE = 
3.01, p < 0.27). Rapid response in EDE-Q global scores predicted 
improvement in the same outcome measure (B = 1.69, SE = 0.28, p < 0.01), 
but not in behavioral measures (p > 0.05). None of the rapid response 
variables were associated with changes in behavioral measures (p > 0.05). 
Contrasts between diagnostic groups or treatment modalities were not 
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statistically significant (p > 0.05) after adjusting for rapid response. 
Sensitivity analyses yielded the same pattern of results described above. 
 
Treatment duration and BMI changes 
After adjusting for baseline BMI, partial correlations between log-
transformed sessions and BMI change scores were not statistically 
significant in the full sample of cases with available BMI data (n = 32, r = 
0.19, p = 0.30), nor in the subsample of AN cases (n = 22, r = 0.17, p = 0.47). 
 
DISCUSSION 
 
The present study set out to examine the relationship between 
treatment duration and improvement in eating disorders pathology in 
community based psychological treatment. Approximately 1 in 2 patients in 
this sample met criteria for reliable and clinically significant improvement in 
EDE-Q global scores. Pre-post treatment effect sizes were moderate for 
behavioral changes (d = 0.32 to 0.41) and large for EDE-Q global scores (d = 
1.42) and BMI gain in anorexia nervosa cases (d = 0.89). Overall, we found 
little evidence of associations between treatment duration and changes in 
attitudinal (EDE-Q global scores), behavioral (binge eating, purging) and 
physical (BMI) outcome indicators. Initial results suggested that longer 
duration of therapy may be associated with improvements in purging 
behaviors; however this was no longer significant after adjusting for rapid 
response variables.  
There are a number of limitations that warrant attention. Sample size 
constraints precluded more detailed contrasts between each of the 
diagnostic categories. A considerable issue related to data which were not 
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missing at random, since approximately 20% of cases dropped out before 
completing final outcome measures. To overcome this potential problem, we 
took a rigorous approach to deal with missing data,25,30 applying a 
combination of multiple imputation and inverse probability weighting. We 
were also unable to determine the exact time-point (i.e., session) at which 
symptomatic changes occurred, given the infrequent assessment points.  
To some extent, these findings reflect the narrative of clinical 
guidelines for the management of eating disorders,2 which are not very 
specific or prescriptive about the expected duration of psychological care. It 
is difficult to predict how long treatment should last for individual patients 
and there is little evidence that longer treatments lead to better outcomes in 
eating disorder pathology. In spite of this, we note that in clinical practice 
the duration of treatment is often considerably lengthy. For example, a 
recent survey of 157 patients with eating disorders accessing cognitive 
behavioral interventions revealed that they received a mean of 43.82 
sessions, ranging from 1 to 400.31 In particular, clinicians may be more 
inclined to offer lengthy treatment to AN cases.31 The current clinical wisdom 
suggests that AN cases require longer treatments to regain weight,1,2 and 
therefore attending to BMI change is of critical importance in addition to 
EDE-Q measures. However, we found no significant associations between 
treatment duration and BMI gain, although this small sample of AN cases 
may not be representative of more severe cases typically seen in inpatient 
settings. 
Our findings converge with studies that have shown that early 
improvements in eating disorder pathology are predictive of post-treatment 
outcomes.4-9 However, our results indicate that specifically rapid response in 
EDE-Q global scores is a helpful prognostic indicator, whereas early changes 
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in binge eating and purging were not predictive of final treatment outcomes. 
Monitoring rapid response seems to be a clinically sensible strategy to 
inform the management of eating disorder pathology, consistent with 
evidence-based interventions for eating disorders8 and a stepped care 
approach.32  
These findings underline the importance of routine outcome 
measurement and the early review of treatment response. For example, 
patients who have shown rapid response in EDE-Q global scores during the 
first month or so are more likely to be responders, and thus an extension of 
treatment may be justifiable. On the other hand, cases without rapid 
response are much less likely to benefit from therapy, and considering 
obstacles to improvement (or alternative support options) at that early review 
point may be important. In summary, we recommend regular outcome 
monitoring and review of progress within the early stages of treatment to 
inform future treatment planning and to determine the duration of an 
outpatient episode of psychological therapy. Future research could assess 
the acceptability and clinical effectiveness of such a decision-making 
strategy in psychological care for eating disorders. 
LENGTH OF THERAPY FOR E.D. 
 15 
 
Acknowledgements 
 
We thank Leah Stocken, Joanne Ormiston and Jenna Sellis who assisted 
with data collection and preparation. 
LENGTH OF THERAPY FOR E.D. 
 16 
 
References 
 
1. American Psychiatric Association. Practice Guideline for the treatment of 
patients with eating disorders, third edition. APA, 2006. 
 
2. National Institute for Health and Clinical Excellence. Eating disorders. 
Core interventions in the treatment and management of anorexia 
nervosa, bulimia nervosa and related eating disorders. CG9. London, 
UK: National Institute for Health and Clinical Excellence; 2004. 
 
3. Hay PP, Bacaltchuk J, Stefano S, Kashyap P. Psychological treatments for 
bulimia nervosa and binging. Cochrane Database Syst Rev 
2009;7(4):CD000562. doi: 10.1002/14651858.CD000562.pub3. 
 
4. Vall E, & Wade TD. Predictors of Treatment Outcome in Individuals with 
Eating Disorders: A Systematic Review and Meta-Analysis. Int J Eat 
Disord 2015;48(7):946–971.  
 
5. Doyle PM, Le Grange D, Loeb K, Doyle AC, Crosby RD. Early Response to 
Family-Based Treatment for Adolescent Anorexia Nervosa. Int J Eat 
Disord 2010;43:659–662. 
 
6. Grilo CM, White MA, Wilson GT, Gueorguieva R, & Masheb RM. Rapid 
response predicts 12-month post-treatment outcomes in binge-eating 
disorder: theoretical and clinical implications. Psychol Med 
2012;42:807–817. 
LENGTH OF THERAPY FOR E.D. 
 17 
 
7. MacDonald DE, Trottier K, McFarlane T, & Olmsted MP. Empirically 
defining rapid response to intensive treatment to maximize prognostic 
utility for bulimia nervosa and purging disorder. Behav Res Ther 
2015;68:48–53. 
 
8. Raykos BC, Watson HJ, Fursland A, Byrne SM, & Nathan P. Prognostic 
Value of Rapid Response to Enhanced Cognitive Behavioral Therapy in a 
Routine Clinic Sample of Eating Disorder Outpatients. Int J Eat Disord 
2013;46:764–770. 
 
9. Turner H, Bryant-Waugh R, & Marshall E. The impact of early symptom 
change and therapeutic alliance on treatment outcome in cognitive-
behavioural therapy for eating disorders. Behav Res Ther 2015;73:165-
169. 
 
10. Howard KI, Kopta SM, Krause MS, & Orlinsky DE. The dose–effect 
relationship in psychotherapy. Am Psychol 1986;41:159–164. 
 
11. Anderson EM, & Lambert MJ. A survival analysis of clinically significant 
change in outpatient psychotherapy. J Clin Psychol 2001;57:875–888. 
 
12. Barkham M, Rees A, Stiles WB, Shapiro DA, Hardy GE, & Reynolds S. 
Dose–effect relations in time-limited psychotherapy for depression. J 
Consult Clin Psychol 1996;64:927–935. 
 
LENGTH OF THERAPY FOR E.D. 
 18 
13. Delgadillo J, McMillan D, Lucock M, Leach C, Ali S, & Gilbody S. Early 
changes, attrition, and dose–response in low intensity psychological 
interventions. Br J Clin Psychol 2014;53:114–130. 
 
14. Hansen NB, & Lambert MJ. An Evaluation of the Dose–Response 
Relationship in Naturalistic Treatment Settings Using Survival Analysis. 
Ment Health Serv Res 2003;5(1):1-12. 
 
15. Kadera SC, Lambert MJ, & Andrews AA. How much therapy is really 
enough? A session-by-session analysis of the psychotherapy dose–effect 
relationship. J Psychother Pract Res1996;5:132–151. 
 
16. Kopta SM, Howard KI, Lowry JL, & Beutler LE. Patterns of symptomatic 
recovery in psychotherapy. J Consult Clin Psychol 1994;62:1009–1016. 
 
17. Maling MS, Gurtman MB, & Howard KI. The response of interpersonal 
problems to varying doses of psychotherapy. Psychother Res 1995;5:63–
75. 
 
18. American Psychiatric Association. Diagnostic and statistical manual of 
mental disorders (4th ed.). Washington, DC: American Psychiatric Press, 
1994. 
 
19. Fairburn CG, & Beglin SJ. Assessment of eating disorders: Interview or 
self-report questionnaire? Int J Eat Disord 1994;16:363–370. 
 
LENGTH OF THERAPY FOR E.D. 
 19 
20. Bohn K, Fairburn CG. The Clinical Impairment Assessment 
Questionnaire (CIA 3.0). In Fairburn C.G. (ed). Cognitive Behavior 
Therapy and Eating Disorders. New York: Guilford Press, 2008. 
 
21. Luce KH, & Crowther JH. The reliability of the Eating Disorder 
Examination-Self-Report Questionnaire version (EDEQ). Int J Eat Disord 
1999;25:349–351. 
 
22. Mond JM, Hay PJ, Rodgers B, Owen C, & Beumont PJV. Validity of the 
Eating Disorders Examination Questionnaire (EDE-Q) in screening for 
eating disorders in community samples. Behav Res Ther 2004;42:551–
567. 
 
23. American Psychiatric Association. Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV), 4th edition. American Psychiatric Press, 
Washington, 1994. 
 
24. Schafer JL, & Olsden MK. Multiple imputation for multivariate missing-
data problems: A data analyst's perspective. Multivariate Behav Res 
1998;33:545-571. 
 
25. Curtis LH, Hammill BG, Eisenstein EL, Kramer JM, & Anstrom KJ. 
Using Inverse Probability-Weighted Estimators in Comparative 
Effectiveness Analyses With Observational Databases. Med Care 
2007;45:S103–S107. 
 
 
LENGTH OF THERAPY FOR E.D. 
 20 
26. Jacobson NS, & Truax P. Clinical significance: A statistical approach to 
defining meaningful change in psychotherapy research. J Consult Clin 
Psychol 1991;59(1):12–19. 
 
27. Mond JM, Hay PJ, Rodgers B, Owen C. Eating disorder examination 
questionnaire (EDE-Q): norms for young adult women. Behav Res Ther 
2006; 44:53–62. 
 
28. Bardone-Cone AM, Harney MB, Maldonado CR, Lawson MA, Robinson 
DP, Smith R, Tosh A. Defining recovery from an eating disorder: 
Conceptualisation, validation, and examination of psychosocial 
functioning and psychiatric comorbidity. Behav Res Ther 2010; 48:194–
202. 
 
29. Couturier J, Lock J. What is recovery in adolescent anorexia nervosa? 
Int J Eat Disord 2006; 39:550–555. 
 
30. Seaman S, & White I. Re-analysis using Inverse Probability Weighting 
and Multiple Imputation of Data from The Southampton Women’s 
Survey. Cambridge: Institute of Public Health; 2008. 
 
31. Cowdrey ND, & Waller G. Are we really delivering evidence-based 
treatments for eating disorders? How eating-disordered patients describe 
their experience of cognitive behavioral therapy. Behav Res Ther 
2015;75:72–77. 
 
LENGTH OF THERAPY FOR E.D. 
 21 
32. Bower P, & Gilbody S. Stepped care in psychological therapies: access, 
effectiveness and efficiency: narrative literature review. Br J Psychiatry 
2005;186:11–17.
LENGTH OF THERAPY FOR E.D. 
 22 
Table 1. Pre- and post-treatment outcome measures 
 
  
Pre-treatment 
measure 
 
Post-treatment 
measure 
  
 
Pre-post effect size 
  
 
Response rates 
Outcome measure Mean (SD) Mean (SD)  Cohen’s d 95% CI  %RR %RCSI 
EDE-Q global score 4.31 (1.24) 2.54 (1.45)  1.42 1.19, 1.65  34.8 54.5 
EDE-Q binge eating 7.04 (10.29) 2.82 (4.72)  0.41 0.25, 0.57  31.3  
EDE-Q purging 7.28 (11.54) 3.54 (7.21)  0.32 0.17, 0.48  21.7  
BMI (AN + EDNOS) 17.96 (1.82) 18.87 (2.15)  0.49 0.22, 0.75    
BMI (AN) 17.02 (1.09) 18.03 (1.79)  0.89 0.45, 1.33    
Notes: EDE-Q = eating disorder examination questionnaire; EDE-Q binge eating and purging = number of episodes in the last month; BMI 
= body mass index; AN = anorexia nervosa sample; EDNOS = sample of atypical anorexia nervosa cases with healthy range BMI; SD = 
standard deviation; CI = confidence intervals; RR = rapid response in the relevant measure by treatment session 8, for cases with at least 9 
treatment sessions; RCSI = reliable and clinically significant improvement in EDE-Q global scores 
 
 
 
 
